课题基金 / 基金详情

DISEASE SUSCEPTIBILITY GENES IN PEDIATRIC ANTIPHOSPHOLIPID ANTIBODY SYNDROME

DISEASE SUSCEPTIBILITY GENES IN PEDIATRIC ANTIPHOSPHOLIPID ANTIBODY SYNDROME
儿童抗磷脂抗体综合征的疾病易感基因
批准号:
6235673
负责人:
EMILY VON SCHEVEN
金额:
$9.33万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-01 至 1997-12-31

项目摘要

项目成果

EMILY VON SCHEVEN的其他基金

相关文献

中文摘要
翻译
抗磷脂抗体综合征(APS)是一种血栓性疾病 以血栓形成与定向抗体相关为特征的 对抗磷脂。除了蛋白C,S蛋白还有抗凝血酶 III缺乏症和因子V莱顿突变,APS构成 儿童血栓形成的重要原因通常没有被认识到 由儿科医生提供。APS既作为一种继发性疾病存在于 与系统性红斑狼疮(SLE)相关,并作为原发病 没有潜在风湿性疾病的综合症。 抗磷脂抗体(APL)是异质性的,可以 用几种不同的化验方法检测。虽然这一综合征 近年来在文学上受到越来越多的关注,有 关于抗体检测、抗原性仍有许多悬而未决的问题 目标、诊断、发病机制和适当的临床处理。 此外,还有关于诊断、预后、 以及儿科人群的管理。二级专业 组织复制复合体(MHC)基因编码相关分子 随着对自我和非我的区分,抗原的呈递 免疫激活和调节T细胞识别。第II类 此前,MHC基因与疾病易感性相关 几种风湿性和非风湿性疾病 调查人员。有证据表明,第二类MHC协会可能 APL的表达和APS的后续发展存在于 成人,但尚未在儿童中广泛研究。不是全部 循环中的急性早幼粒细胞白血病患者随后会发展为急性胰腺炎。和 最近,β2-糖蛋白I已被证明是重要的 在检测确实有血栓形成的个体的APL时。 证据支持第五结构域的磷脂结合作用,以及 因此,该区域的多态性可能与APS有关。这个 该项目的目的是识别疾病易感基因, 可能是一组儿童的特征,他们有更高的 血栓形成的发展,并可能导致 了解这种疾病的发病机制。
英文摘要
Antiphospholipid antibody syndrome (APS) is a thrombotic disorder characterized by the association of thrombosis with antibodies directed against phospholipids. In addition to protein C, protein S, antithrombin III deficiency, and Factor V Leiden mutation, APS constitutes a significant cause of thrombosis in children that is often no recognized by pediatricians. APS exists both as a secondary disorder in association with systemic lupus erythematosus (SLE), and as a primary syndrome in the absence of underlying rheumatic disorders. Antiphospholipid antibodies (aPL) are heterogeneous and can be detected by several different assays. Although the syndrome has received increased attention in the literature in recent years, there are still many unanswered questions regarding antibody detection, antigenic target, diagnosis, pathogenesis, and appropriate clinical management. Furthermore, there are unique issues regarding diagnosis, prognosis, and management in the pediatric population. Class II Major Histocopatibility Complex (MHC) genes encode molecules involved with the discrimination of self and non-self, presentation of antigen for immuneactivation, and modulation of T cell recognition. Class II MHC genes have previously been correlated with disease susceptibility for several rheumatic and non-rheumatic disorders by other investigators. Evidence suggests that Class II MHC associations may exist for the expression of aPL and subsequent development of APS in adults, and has not been studied extensively in children. Not all individuals with circulating aPL subsequently develop APS. And recently, Beta 2-Glycoprotein I has been demonstrated to be important in the detection of aPL from individuals who do develop thromboses. Evidence supports a phospholipid binding role for the fifth domain, and thus polymorphism of this region may be associated with APS. The purpose of this project is to identify disease susceptibility genes which may characterize a subgroup of children at increased risk for the development of thrombosis, and potentially contribute to an increased understanding of the pathogenesis of this disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LONG TERM OUTCOME OF CHILDREN AND ADOLESCENTS WITH APL
BONE MINERAL DENSITY OF CHILDREN AND ADOLESCENTS WITH SLE
BONE MINERAL DENSITY STUDY IN SLE
ALENDRONATE FOR THE TREATMENT OF CHILDHOOD OSTEOPENIA AND OSTEOPOROSIS